Price target upside
Sagimet Biosciences Inc. - Series A Common Stock Price Target Upside or Downside
SGMT price target upside based on the current price and analyst average.
Direct answer
Sagimet Biosciences Inc. - Series A Common Stock's analyst target implies +168.2%.
The average target is $26.20 compared with a recorded current price of $9.77.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Sagimet Biosciences Inc. - Series A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.77
- Average price target
- $26.20
- High price target
- $49.00
- Low price target
- $8.00
- Target upside
- +168.2%
- Consensus rating
- none
- Analysts
- 10
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026